AKT1 and lung adenocarcinoma: This shows the first study in which silence of TF expression in lung adenocarcinoma cells by TF-siRNA could inhibit tumor growth and metastasis in vitro and in vivo, and the antitumor effects may be associated with inhibition of Erk MAPK, PI3K/Akt signal pathways in lung cancer.